The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Avencell Europe competitive analysis

Loading summary...

Latest oppositions filed by Avencell Europe

Explore patent oppositions filed by Avencell Europe against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2651442
Universal Anti-Tag Chimeric Antigen Receptor-Expressing T Cells And Methods Of Treating CancerUNIVERSITY OF MARYLANDJan 20, 2021

Latest PTAB cases involving Avencell Europe

Discover the latest PTAB cases involving Avencell Europe, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Avencell Europe with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AVENCELL EUROPE1 - - -
UNIVERSITY OF MARYLAND - 4 - 2